4//SEC Filing
Collier Kathryn J 4
Accession 0001209191-23-036755
CIK 0001505512other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:47 PM ET
Size
5.7 KB
Accession
0001209191-23-036755
Insider Transaction Report
Form 4
Collier Kathryn J
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+30,000→ 30,000 totalExercise: $1.45Exp: 2033-06-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001737436
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:47 PM ET
- Size
- 5.7 KB